Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

NCT02115815 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02115815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults
Lead sponsor
MedImmune LLC
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
June 30, 2015
Enrollment
246 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv)